Arbutus Biopharma Corporation
ABUS
$4.31
-$0.08-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.38% | -4.47% | -12.97% | -8.09% | -4.05% |
| Total Receivables | 44.98% | 7.11% | -18.60% | -48.98% | 41.98% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -51.16% | -35.10% | 43.66% | 37.05% | -35.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.06% | -5.51% | -11.72% | -8.25% | -4.11% |
|
|
|||||
| Total Current Assets | -3.06% | -5.51% | -11.72% | -8.25% | -4.11% |
| Net Property, Plant & Equipment | -76.64% | -7.43% | -11.90% | -96.14% | -7.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.76% | -- | -- | 0.00% | -- |
| Total Assets | -3.16% | -5.38% | -11.75% | -11.16% | -6.22% |
|
|
|||||
| Total Accounts Payable | 16.02% | -23.47% | -41.03% | -3.28% | 0.04% |
| Total Accrued Expenses | 26.64% | 19.02% | -38.04% | -25.61% | 12.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.01% | 3.31% | -8.70% | 16.56% | 3.21% |
| Total Finance Division Other Current Liabilities | -16.12% | -0.65% | -93.96% | 68.06% | -34.03% |
| Total Other Current Liabilities | -16.12% | -0.65% | -93.96% | 68.06% | -34.03% |
| Total Current Liabilities | 15.86% | 3.23% | -74.15% | 24.41% | -17.47% |
|
|
|||||
| Total Current Liabilities | 15.86% | 3.23% | -74.15% | 24.41% | -17.47% |
| Long-Term Debt | -6.57% | -5.78% | -11.32% | -8.70% | -9.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -49.10% | -32.00% | -8.15% | -22.33% | -17.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -24.04% | 2.49% | -19.44% | 2.28% | 57.02% |
| Total Liabilities | -11.17% | 0.10% | -46.40% | 10.23% | 2.35% |
|
|
|||||
| Common Stock & APIC | 0.19% | 0.14% | 0.09% | 0.43% | 0.21% |
| Retained Earnings | -0.27% | -0.57% | 0.18% | -1.82% | -0.94% |
| Treasury Stock & Other | 0.06% | 0.12% | -0.04% | -0.06% | -0.09% |
| Total Common Equity | -1.06% | -6.72% | 4.82% | -18.70% | -8.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.06% | -6.72% | 4.82% | -18.70% | -8.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.06% | -6.72% | 4.82% | -18.70% | -8.91% |
|
|
|||||